The effect of prophylactic treatment with bepotastine in patients with Japanese cedar pollinosis

Practica Oto-Rhino-Laryngologica

Volumn 95, Issue 5, 2002, Pages 531-537

  Ohta, Nobuo ^a   Akatsuka, Naoko ^a   Saito, Fumiaki ^a   Aoyagi, Masaru ^a   Inamura, Kazutoshi ^b   Noda, Daisuke ^b   Gon, Seigi ^c   Ishida, Akihiro ^c  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Yamagata Prefectural Kahoku Hospital   (Japan)

Author keywords

Bepotastine; Japanese cedar pollinosis; Prophylactic treatment

Indexed keywords

BETOTASTINE;

ARTICLE; DRUG EFFECT; HUMAN; JAPAN; POLLEN ALLERGY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036445234     PISSN: 00326313     EISSN: None     Source Type: Journal    
DOI: 10.5631/jibirin.95.531     Document Type: Article

References (26)

1. Bemardini R, Novembre E, Mugnaini L, et al.: Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis; levocabastine effect. Allergy Asthma Proc 19: 75-80, 1998.
2. Nielsen LP, Bjerke T, Christensen MB, et al.: Eosinophil markers in seasonal allergic rhinitis; intranasal fluticasone propionate inhibits local and systemic increases during the pollen season. Allergy 53: 778-785, 1998.
3. Beppu T, Ohta N, Gon S, et al.: Eosinophil and eosinophil cationic protein in allergic rhinitis. Acta Otolaryngol Suppl (Stockh) 511: 221-223, 1994.
4. Rollins BJ: Chemokines. Blood 90: 909-928, 1997.
5. Leonard EJ, Skeel A, Yoshimura T, et al.: Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J Immunol 144: 1323-1330, 1990.
6. Baggiolini M and Dahinden CA: CC chemokines in allergic inflammation. Immunol Today 15: 127-133, 1994.
7. Yamada H, Hirai K, Miyamasu M, et al.: Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun 231: 365-368, 1997.
8. Ponath PD, Quin S, Ringler DJ, et al.: Cloning of the human eosinophil chemoattractant, eotaxin; expresson, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97: 604-612, 1996.
9. Lamkhioued B, Renzi PM, Abi-Younes S, et al.: Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 159: 4593-4601, 1997.
10. 2+-mobilizatoin, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 88: 3195-3199, 1996.
11. Elsner J, Hochstetter R, Kimmig D, et al.: Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol 26: 1919-1925, 1996.
12. Ueno M, Inagaki N, Nagai H, et al.: Antiallergic action of betotastine besilate (TAU-284) in animal models; a comparison with ketotifen. Pharmacology 57: 206-214, 1998.